Proniras Corporation
PrivateLast Round
Series B
Feb 1, 2024
Total Funding Raised
$21.25M
Company Overview
Proniras Corporation is a clinical-stage biotechnology company developing novel small-molecule therapeutics for the treatment of substance use and specialty central nervous system disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2G
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Proniras Corporation Comparables
Compare Proniras Corporation with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Aether Therapeutics | 80% | |
| Kinoxis Therapeutics | 77% | |
| BioCorRx Inc | 73% | |
Proniras Corporation Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Feb 1, 2024 | ||||
| Grant | Sep 17, 2020 | ||||
| Series A | Jul 12, 2019 | ||||
| Accelerator | Apr 27, 2018 |
Key People
Founding team and executive leadership
Proniras Corporation Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Accelerator Life Science Partners | Series B, Accelerator |
| ARCH Venture Partners | Accelerator, Series B |
| WRF Capital | Series B, Accelerator |
| Public Health Emergency Medical Countermeasures Enterprise | Accelerator |
| ARCH Venture Partners | Accelerator, Series B |
| Washington Research Foundation Capital | Series B, Accelerator |
| Alexandria Venture Investments | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 17, 2020
$12M grant awarded by the National Institute on Drug Abuse.
Proniras Corporation Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Proniras Corporation's valuation, stock price, and market status.